GILEAD SCIENCES, INC. is 55.2x more valuable than Adaptive Biotechnologies Corp by market capitalization ($150.83 B vs $2.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADPT | GILD |
|---|---|---|
| Market cap | $2.73 B | $150.83 B |
| US-listed rank | #1887 | #99 |
| Revenue (latest FY) | $276.98M | $29.44B |
| Net income (latest FY) | -$59.50M | $8.51B |
| Net margin | -21.5% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 764 | 981 |
GILEAD SCIENCES, INC. is 55.2x more valuable than Adaptive Biotechnologies Corp by market capitalization ($150.83 B vs $2.73 B).
In their latest fiscal years, Adaptive Biotechnologies Corp reported $276.98M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: Adaptive Biotechnologies Corp and GILEAD SCIENCES, INC., or browse the full rankings.